Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

KalVista Pharmaceuticals (KALV) Other Operating Expenses (2016 - 2017)

KalVista Pharmaceuticals' Other Operating Expenses history spans 5 years, with the latest figure at $2000.0 for Q2 2025.

  • For Q2 2025, Other Operating Expenses changed N/A year-over-year to $2000.0; the TTM value through Apr 2025 reached $1000.0, changed N/A, while the annual FY2025 figure was -$53.4 million, 49.25% down from the prior year.
  • Other Operating Expenses for Q2 2025 was $2000.0 at KalVista Pharmaceuticals, up from -$1000.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $2000.0 in Q2 2025 and bottomed at -$1000.0 in Q4 2024.